Breaking News Instant updates and real-time market news.

CVS

CVS Health

$79.12

1.15 (1.47%)

06:56
08/08/17
08/08
06:56
08/08/17
06:56

CVS Health reports Q2 adjusted EPS $1.33, consensus $1.31

Reports Q2 revenue $45.7B, consensus $45.37B.

  • 08

    Aug

  • 21

    Sep

  • 22

    Sep

CVS CVS Health
$79.12

1.15 (1.47%)

06/27/17
LEER
06/27/17
NO CHANGE
Target $90
LEER
Outperform
CVS gained largest PBM share in 2017 selling season, says Leerink
Leerink analyst David Larsen says his firm's recently published Pharmacy Benefit Manager survey shows that CVS Health is the largest share gainer in the 2017 selling season. The company is poised to win incremental PBM and Specialty Pharmacy share, while the Optum and Cigna deals will start to benefit retail volumes in the near-term, Larsen tells investors in a research note. He keeps an Outperform rating on CVS shares with a $90 price target.
06/27/17
NEED
06/27/17
INITIATION
NEED
Hold
CVS Health initiated with a Hold at Needham
Needham analyst Kevin Caliendo initiated CVS Health with a Hold.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/18/18
09/18
12:17
09/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$203.42

0.92 (0.45%)

12:17
09/18/18
09/18
12:17
09/18/18
12:17
Hot Stocks
General Dynamics awarded contract by U.S. Air Force for CM-300/350 V2 ATC radios »

General Dynamics Mission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.38

1.97 (0.68%)

12:16
09/18/18
09/18
12:16
09/18/18
12:16
Technical Analysis
Technical Take: SPDR S&P 500 ETF near session highs at midday »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.38

1.97 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
09/18/18
09/18
12:16
09/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$45.74

2.16 (4.96%)

12:09
09/18/18
09/18
12:09
09/18/18
12:09
Technical Analysis
Technical Take: Micron at highs of session on buyback speculation »

RBC Capital issued a note…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

SCOR

comScore

$19.68

0.19 (0.97%)

12:09
09/18/18
09/18
12:09
09/18/18
12:09
Hot Stocks
comScore Canada GM Brent Bernie leaving, Bryan Segal assuming role »

comScore announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

SPWR

SunPower

$7.26

0.68 (10.33%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Periodicals
Breaking Periodicals news story on SunPower »

SunPower CEO:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$18.35

7.95 (76.44%)

, MDGL

Madrigal Pharmaceuticals

$199.85

-28.82 (-12.60%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Recommendations
Viking Therapeutics, Madrigal Pharmaceuticals analyst commentary  »

Viking NAFLD data beat…

VKTX

Viking Therapeutics

$18.35

7.95 (76.44%)

MDGL

Madrigal Pharmaceuticals

$199.85

-28.82 (-12.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

QCOM

Qualcomm

$75.24

1.99 (2.72%)

, AVGO

Broadcom

$239.98

6.88 (2.95%)

12:08
09/18/18
09/18
12:08
09/18/18
12:08
Periodicals
Qualcomm in discussions to add 'at least' two directors to board, Reuters says »

Qualcomm (QCOM) is…

QCOM

Qualcomm

$75.24

1.99 (2.72%)

AVGO

Broadcom

$239.98

6.88 (2.95%)

NXPI

NXP Semiconductors

$91.06

0.91 (1.01%)

AAPL

Apple

$219.48

1.62 (0.74%)

MDLZ

Mondelez

$43.48

-0.24 (-0.55%)

LRCX

Lam Research

$154.85

2.72 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 28

    Oct

TECH

Bio-Techne

$197.07

0.27 (0.14%)

12:04
09/18/18
09/18
12:04
09/18/18
12:04
Hot Stocks
Bio-Techne reports publication of data showing additional validation of EPI test »

Bio-Techne announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$287.07

-7.71 (-2.62%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Technical Analysis
Technical Take: Tesla drops sharply on report of DOJ criminal probe »

The shares have spiked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

VKTX

Viking Therapeutics

$18.62

8.22 (79.04%)

, MDGL

Madrigal Pharmaceuticals

$199.75

-28.92 (-12.65%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Recommendations
Viking Therapeutics, Madrigal Pharmaceuticals analyst commentary  »

H.C. Wainwright boosts…

VKTX

Viking Therapeutics

$18.62

8.22 (79.04%)

MDGL

Madrigal Pharmaceuticals

$199.75

-28.92 (-12.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

A

Agilent

$68.76

-0.32 (-0.46%)

12:03
09/18/18
09/18
12:03
09/18/18
12:03
Hot Stocks
Agilent files new complaint against Twist Bioscience regarding stolen documents »

Agilent Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

SEAS

SeaWorld

$31.13

-0.05 (-0.16%)

12:01
09/18/18
09/18
12:01
09/18/18
12:01
Periodicals
Breaking Periodicals news story on SeaWorld »

SeaWorld sued by SEC for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBEV

New Age Beverages

$2.57

0.26 (11.26%)

12:01
09/18/18
09/18
12:01
09/18/18
12:01
Recommendations
New Age Beverages analyst commentary  »

New Age Beverages to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$12.61

-0.105 (-0.83%)

12:00
09/18/18
09/18
12:00
09/18/18
12:00
Options
Notable buying in GE short-term puts as shares see relative weakness »

Notable buying in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

NEE

NextEra Energy

$173.18

-0.67 (-0.39%)

11:56
09/18/18
09/18
11:56
09/18/18
11:56
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 11

    Nov

GIS

General Mills

$44.08

-3.69 (-7.72%)

, KHC

Kraft Heinz

$56.96

-1.39 (-2.38%)

11:56
09/18/18
09/18
11:56
09/18/18
11:56
Hot Stocks
General Mills plunges after reporting North America sales decline »

Shares of General Mills…

GIS

General Mills

$44.08

-3.69 (-7.72%)

KHC

Kraft Heinz

$56.96

-1.39 (-2.38%)

SJM

J.M. Smucker

$110.00

-1.66 (-1.49%)

CPB

Campbell Soup

$39.92

-1.04 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 09

    Oct

  • 28

    Oct

11:55
09/18/18
09/18
11:55
09/18/18
11:55
General news
Treasury's $40 B 4-week bill auction was strong on several counts »

Treasury's $40 B…

11:55
09/18/18
09/18
11:55
09/18/18
11:55
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail/Hardlines Analyst…

11:55
09/18/18
09/18
11:55
09/18/18
11:55
Conference/Events
Jefferies strategy and tech team to hold a luncheon meeting »

Best Ideas & Strategy…

BABA

Alibaba

$157.03

-1.73 (-1.09%)

11:54
09/18/18
09/18
11:54
09/18/18
11:54
Recommendations
Alibaba analyst commentary  »

SunTrust incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

TSLA

Tesla

$301.59

6.81 (2.31%)

11:50
09/18/18
09/18
11:50
09/18/18
11:50
Hot Stocks
Tesla said to face criminal probe alongside civil inquiry »

Tesla, which is already…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

SGMS

Scientific Games

$26.65

1.775 (7.14%)

11:50
09/18/18
09/18
11:50
09/18/18
11:50
Options
Longer-term call buying in Scientific Games as shares spike off 52-week lows »

Longer-term call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$75.32

2.07 (2.83%)

11:47
09/18/18
09/18
11:47
09/18/18
11:47
Periodicals
Breaking Periodicals news story on Qualcomm »

Qualcomm in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.